Skip to main content
. Author manuscript; available in PMC: 2020 Jan 1.
Published in final edited form as: Lancet Haematol. 2018 Dec 10;6(1):e29–e37. doi: 10.1016/S2352-3026(18)30182-0

Table 2.

Response rates

Best response Decitabine x 5 days
n (%)
Decitabine x 10 days
n (%)
P
CR 8 (29) 13 (30) 0.88
CRp 3 (11) 2 (5)
Cri 1 (4) 2 (5)
 CR + CRp + CRi 12 (43) 17 (40) 0.78
PR 0 1 (2)
No response 15 (54) 22 (51)
Early death 1 (4) 3 (7)

CR, complete remission; CRp, complete remission without platelet recovery; CRi, complete remission with inadequate count recovery; PR, partial remission

The 95% credible interval for the composite response rate of CR + CRp + CRi (primary outcome) is (0.26, 0.60) for the 5-day schedule and (0.26, 0.54) for the 10-day schedule. The difference in overall response rate between groups was 3% (95% credible interval [−0.21, 0.27]).